GlaxoSmithKline (NYSE: GSK) and EPIX Pharmaceuticals (NASDAQ: EPIX) announced a worldwide multi-target strategic collaboration to discover, develop and market novel ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE